Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001865694 | SCV002240937 | pathogenic | not provided | 2022-08-21 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 2-3 of the PRKN gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. A similar copy number variant has been observed in individuals with early-onset Parkinson's disease (PMID: 10824074, 17914726, 21215313, 23880019). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV000531632 | SCV000645375 | pathogenic | Autosomal recessive juvenile Parkinson disease 2 | 2017-12-22 | flagged submission | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exons 2-3 of the PARK2 gene. It preserves the integrity of the reading frame. This variant has been reported in the compound heterozygous state in several individuals affected with early-onset Parkinson's disease (PMID: 21215313, 17914726, 23880019, 10824074). For these reasons, this variant has been classified as Pathogenic. |